I don’t know if I could take another otc stock,
Post# of 148181
(Total Views: 485)
Posted On: 10/07/2019 9:47:27 PM
I don’t know if I could take another otc stock, not because of the potential, but just a few shareholders. Verb hit $18 a few months ago and is now $1 and they have less complaining on that board. I’ve seen many biotech tank prerevenue, all in all the sp is holding. A few comments some might need to understand...
1) This is an otc stock. All otc stocks have horrible financing, otherwise they would be nasdaq or nyse stock.
2) This is a gamble, don’t treat it otherwise, don’t invest money in any otc stock that you can’t offered to lose. It could go to zero, it has the potential to go to $10. If you want a stable investment invests in cds, bonds, index stock. Don’t invest in higher speculative otc stock like cydy and act like a baby...good grief.
3) Do your own DD. I’m here because of leronlimab. I believe it will be a game changer and management is just competitive enough to get it over the finish line. I’ve researched myself enough that I feel comfortable with my investment even with the declining share price, because I believe ultimately the drug will win out. It is close to approval, so it is about there.
4) The share price might not change until revenue is reached. It’s hard to raise $50M per year selling stock and the share not go down.
5) NP isn’t going anywhere. Complaining about it will not change that. He has done some amazing things, he has done some bone-headed things, but we are stuck with him good or bad. The BOD just gave him a huge raise, how do you think they feel about him? And as otc ceo’s go, and I have seen a lot of them, you are fairly lucky compared to many others I have seen. There is not a nasdaq ceo sitting around wanting the punishment NP has endured getting this to the finish line. If you are holding on, thinking NP will be replaced, I would get out now, not going to happen. I don’t waste my time complaining about something that isn’t going to change.
All imo.
1) This is an otc stock. All otc stocks have horrible financing, otherwise they would be nasdaq or nyse stock.
2) This is a gamble, don’t treat it otherwise, don’t invest money in any otc stock that you can’t offered to lose. It could go to zero, it has the potential to go to $10. If you want a stable investment invests in cds, bonds, index stock. Don’t invest in higher speculative otc stock like cydy and act like a baby...good grief.
3) Do your own DD. I’m here because of leronlimab. I believe it will be a game changer and management is just competitive enough to get it over the finish line. I’ve researched myself enough that I feel comfortable with my investment even with the declining share price, because I believe ultimately the drug will win out. It is close to approval, so it is about there.
4) The share price might not change until revenue is reached. It’s hard to raise $50M per year selling stock and the share not go down.
5) NP isn’t going anywhere. Complaining about it will not change that. He has done some amazing things, he has done some bone-headed things, but we are stuck with him good or bad. The BOD just gave him a huge raise, how do you think they feel about him? And as otc ceo’s go, and I have seen a lot of them, you are fairly lucky compared to many others I have seen. There is not a nasdaq ceo sitting around wanting the punishment NP has endured getting this to the finish line. If you are holding on, thinking NP will be replaced, I would get out now, not going to happen. I don’t waste my time complaining about something that isn’t going to change.
All imo.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼